Activin is an ovarian-produced protein that regulates follicle function. The investigators hypothesize that the ability of follicles to respond to activin is controlled by the type of receptor subunits present on the cell membrane. Therefore, the investigators will investigate the presence of activin receptor subunits (RII-ligand binding and RI-signal transduction) in the granulosa cell at times following hormonal stimulation. Receptor activation stimulates cytoplasmic signaling molecules. Candidate signal proteins have been identified (Smad2 and Smad4) and the investigators have shown that these proteins are activated by activin in granulosa cells. They hypothesize that normal, activin-regulated granulosa cell function is dependent on the appropriate interaction of ligand with Smad2 or Smad4 and that alteration in the activin signal transduction pathway will lead to abnormal follicle function. These tenets will be tested in granulosa cell culture and in transgenic animals. The transcriptional response of activin-regulated promoters (p3TP and junB) will be measured following over-expression of normal or mutated signal proteins in a granulosa cell line, GRM02. The genetic sequence that is responsive to activin signals will be identified (activin-response element or ARE). Transgenic animals with ovarian-targeted (inhibin alpha subunit promoter) mutated signal protein (Smad2-dominant negative) or normal and mutated receptor (ActRII-dominant negative and ActRII-constitutively active) will be generated and the consequence of over expression of these proteins will be evaluated in terms of follicle growth, selection, and maturation. These studies will establish the causal relationship between the activin system and normal and abnormal follicle function.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD035708-02
Application #
2889413
Study Section
Reproductive Endocrinology Study Section (REN)
Program Officer
De Paolo, Louis V
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Wang, E Y; Ma, E Y; Woodruff, T K (2003) Activin signal transduction in the fetal rat adrenal gland and in human H295R cells. J Endocrinol 178:137-48
Jeruss, Jacqueline S; Sturgis, Charles D; Rademaker, Alfred W et al. (2003) Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. Cancer Res 63:3783-90
Jeruss, Jacqueline S; Santiago, Jose Y; Woodruff, Teresa K (2003) Localization of activin and inhibin subunits, receptors and SMADs in the mouse mammary gland. Mol Cell Endocrinol 203:185-96
Wang, Eileen Y; Woodruff, Teresa K; Moawad, Atef et al. (2002) Follistatin-free activin A is not associated with preterm birth. Am J Obstet Gynecol 186:464-9
Pangas, Stephanie A; Rademaker, Alfred W; Fishman, David A et al. (2002) Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab 87:2644-57
Narula, Anita; Kilen, Signe; Ma, Eva et al. (2002) Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice. Am J Pathol 161:1723-34
Chapman, Stacey C; Bernard, Daniel J; Jelen, Jaroslav et al. (2002) Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Mol Cell Endocrinol 196:79-93
Bernard, D J; Chapman, S C; Woodruff, T K (2001) An emerging role for co-receptors in inhibin signal transduction. Mol Cell Endocrinol 180:55-62
Chen, W; Woodruff, T K; Mayo, K E (2000) Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins. Endocrinology 141:1263-72
Pangas, S A; Woodruff, T K (2000) Activin signal transduction pathways. Trends Endocrinol Metab 11:309-14